Optimizing outcomes in acute pancreatitis: the impact of of heparin therapy duration on mortality in a multi-center retrospective study
In critically ill patients with acute pancreatitis, heparin therapy lasting less than 4 days was associated with increased 30-day and 90-day mortality, whereas the lowest mortality was observed among patients receiving heparin therapy for approximately 7 days.
Authors
- Linlin Fu
- Qiaoling Zhu (ORCID: https://orcid.org/0000-0002-0923-5629)
- Hanyang Li (ORCID: https://orcid.org/0000-0003-0464-5546)
- Baoyan Wang (ORCID: https://orcid.org/0000-0003-2661-2382)
- Qian Ni
Institutions
- Nanjing University of Chinese Medicine (CN)
- Nanjing Drum Tower Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1186/s12876-025-03763-9
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00